Skip to content
10-Q

Quarterly Report

BioCorRx Inc. BICX

0001477932-25-008319

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q3 2025 · Sep 30, 2025 18.16M sh
Shares Diluted Q3 2025 · Sep 30, 2025 16.9M sh
Shares Diluted Q3 2025 · Sep 30, 2024 10.91M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 9.71M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$1.45M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$849.08K
Stockholders Equity Q3 2025 · Sep 30, 2025 −$13.48M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$12.12M
Current Liabilities Q3 2025 · Sep 30, 2025 $15.04M
Current Liabilities Q3 2025 · Dec 31, 2024 $8.21M
Total Liabilities Q3 2025 · Sep 30, 2025 $20.3M
Total Liabilities Q3 2025 · Dec 31, 2024 $12.74M
Current Assets Q3 2025 · Sep 30, 2025 $1.46M
Current Assets Q3 2025 · Dec 31, 2024 $118K
Total Assets Q3 2025 · Sep 30, 2025 $7.53M
Total Assets Q3 2025 · Dec 31, 2024 $385.94K
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.11
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.24
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.14
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.41
Sga Expense Q3 2025 · Sep 30, 2025 $1.15M
Sga Expense Q3 2025 · Sep 30, 2025 $3.25M
Sga Expense Q3 2025 · Sep 30, 2024 $1.19M
Sga Expense Q3 2025 · Sep 30, 2024 $2.77M
Rd Expense Q3 2025 · Sep 30, 2025 $1M
Rd Expense Q3 2025 · Sep 30, 2025 $1.46M
Rd Expense Q3 2025 · Sep 30, 2024 $460.14K
Rd Expense Q3 2025 · Sep 30, 2024 $1.21M
Net Income Q3 2025 · Sep 30, 2025 −$1.92M
Net Income Q3 2025 · Sep 30, 2025 −$3.99M
Net Income restated Q3 2025 · Sep 30, 2024 −$1.49M
Net Income Q3 2025 · Sep 30, 2024 −$3.94M
Operating Income Q3 2025 · Sep 30, 2025 −$1.95M
Operating Income Q3 2025 · Sep 30, 2025 −$4.3M
Operating Income Q3 2025 · Sep 30, 2024 −$1.66M
Operating Income Q3 2025 · Sep 30, 2024 −$4M
Revenue Q3 2025 · Sep 30, 2025 $635.22K
Revenue Q3 2025 · Sep 30, 2025 $948.36K
Revenue Q3 2025 · Sep 30, 2024 $0
Revenue Q3 2025 · Sep 30, 2024 $7.67K
Shares Outstanding Q3 2025 · Aug 8, 2025 23.69M sh